Repligen to buy BioLife in $1.5 billion deal to expand cell therapy business

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Earnings call transcript: Chubb beats Q2 2026 estimates, stock slips after hours Hisse Senetleri 0 1
A Earnings call transcript: Wabtec tops Q2 2026 estimates, lifts outlook as shares jump Hisse Senetleri 0 1
A Investors brace for Gentherm earnings as margin targets loom Hisse Senetleri 0 1
A Earnings call transcript: Bank OZK tops Q2 2026 estimates on margin gains Hisse Senetleri 0 1
A Form 4 Repligen Corporation For: 17 July Hisse Senetleri 0 2
A Form DEF 14A Repligen Corporation For: 2 April Hisse Senetleri 0 18
A Repligen at Jefferies London: Strategic Growth Amid Headwinds Hisse Senetleri 0 28
A Repligen at Stifel Conference: Strong Growth Amid Challenges Hisse Senetleri 0 36

Benzer konular

Üst